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Abstract
Holocarboxylase synthetase (HCS) is a chromatin protein that is essential for mediating the
covalent binding of biotin to histones. Biotinylation of histones plays crucial roles in the
repression of genes and repeats in the human genome. We tested the feasibility of DNA adenine
methyltransferase identification (DamID) technology to map HCS binding sites in human
mammary cell lines. Full-length HCS was fused to Dam for subsequent transfection into breast
cancer (MCF-7) and normal breast (MCF-10A) cells. HCS docking sites in chromatin were
identified by using the unique adenine methylation sites established by Dam in the fusion
construct; docking sites were unambiguously identified using methylation sensitive digestion,
cloning, and sequencing. Fifteen novel HCS binding sites were identified in the two cell lines and
the following four out of the 15 overlapped between MCF-7 and MCF-10A cells: inositol
polyphosphate-5-phosphatase A, corticotropin hormone precursor, ribosome biogenesis regulatory
protein, and leptin precursor. We conclude that DamID is a useful technology to map HCS binding
sites in human chromatin and propose that the entire set of HCS binding sites could be mapped by
combining DamID with microarray technology.
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1. Introduction
Holocarboxylase synthetase (HCS) is a chromatin protein [1] that plays a pivotal role in
catalyzing histone biotinylation [1,2]. Histone biotinylation is a recently discovered
epigenetic mark [3]. Biotin is unique because biotin serves as an essential covalently bound
cofactor for several mammalian carboxylases and also functions as a covalent histone
modification. Initially, biotinylation of histones was thought to be catalyzed by biotinidase
[4]. However, subsequent studies revealed that HCS is much more important than
biotinidase for biotinylation of histones in vivo [1,5,6,7], despite biotinidase demonstrating
histone biotinyl transferase activity in vitro [8,9,10]. Several histone biotinylation sites have
been identified using recombinant histone biotin ligases, including HCS, and synthetic
*Corresponding Author: Dr. Janos Zempleni, 316C Ruth Leverton Hall, University of Nebraska at Lincoln, Lincoln, NE 68583,
jzempleni2@unl.edu, Telephone Number: (402) 472-3270.
cContributed equally to this project
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Anal Biochem. Author manuscript; available in PMC 2012 June 1.
Published in final edited form as:
Anal Biochem. 2011 June 1; 413(1): 55–59. doi:10.1016/j.ab.2011.02.001.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
histone tail peptides. The identified biotinylation sites are lysine (K)-9, K13, K125, K127,
and K129 in histone H2A [9]; K4, K9, K18, and perhaps K23 in histone H3 [7,10]; and K8
and K12, and perhaps K5 and K16 in histone H4 [7,8,11]. In vitro biotinylation of K8, K12,
and K16 in histone H4 has been confirmed by mass spectrometric analysis of mammalian
histones [11]. The existence of biotinylated histones was recently questioned [12], but
findings in three independent laboratories [13,14,15], in addition to ours [2,3,8,7,10,16],
suggest that biotinylation is a natural histone modification. One might consider the evidence
in two of these publications circumstantial [13,14]. However, the third study used LC/MS/
MS to unambiguously demonstrate that about 50% of the histones in Candida albicans are
biotinylated [15].
Histone biotinylation is a relatively rare event; less than 0.1% of histones are biotinylated in
humans [3,13]. However, the abundance of an epigenetic mark is not the sole determinant its
biologic importance. For example, only ~3% of cytosines are methylated, but the role of
DNA methylation in gene regulation is substantial and undisputed [17]. Likewise, serine-14
phosphorylation in histone H2B and histone poly(ADP-ribosylation) are detectable only
after induction of apoptosis and major DNA damage, respectively; yet the role of these
epigenetic marks in cell death is unambiguous [18–20]. Despite the low global abundance of
biotinylated histones, the epigenetic mark appears to be highly enriched in specific loci,
consistent with its regulatory function. For example, evidence suggests that about one out of
three histone H4 molecules are biotinylated at K12 in telomeric repeats [21]. Moreover,
K12-biotinylated histone H4 (H4K12bio), K9-biotinylated H3 (H3K9bio), and K18-
biotinylated H3 (H3K18bio) are enriched at transcriptionally repressed loci in mammalian
genomes, suggesting a role for histone biotinylation in gene regulation [5,6,16,22]. The
important role of HCS and subsequent biotinylation of histones has been confirmed in
various studies. For example, phenotypes of HCS knockdown include decreased life span
and heat survival in Drosophila melanogaster [1], and increased transcriptional activity of
retrotransposons in metazoans, predisposing test organisms to chromosomal instability [6].
HCS has a dispersed and distinct distribution in chromatin; however its chromatin binding
sites are poorly defined [1]. Therefore, the objective of this study was to employ DNA
adenine methyl transferase identification (DamID) technology [23] to generate the first
insight into HCS chromatin binding sites and to pave the way for more comprehensive
mapping efforts in future studies. Briefly, DamID technology is based on fusing DNA
adenine methyltransferase (Dam) from Escherichia coli to a chromatin protein or
transcription factor of interest [23], e.g., HCS. Upon expression of the fusion protein in
cultured cells or in an intact organism such as Drosophila, HCS guides Dam to HCS binding
sites, where Dam creates a unique adenine methylation tag, which is absent in most
eukaryotes [24]. Adenine methylation sites can be identified by methylation-sensitive
sequencing procedures.
In this proof-of-concept study, DamID technology was used in mammary epithelial cell lines
to map genomic HCS-binding sites in human chromatin for the first time, thereby
identifying potential aberrant epigenetic marks in breast cancer and setting the ground for
future breast cancer studies.
2. Materials and Methods
2.1 Cloning HCS-Dam fusion plasmid
The pIND (V5) EcoDam [23,25] vector was obtained from Dr. Bas van Steensel’s
laboratory at the Netherlands Cancer Institute. pIND (V5) EcoDam codes for E.coli Dam,
and contains a multiple cloning site upstream of the Dam open reading frame. An HCS-Dam
fusion construct was generated as follows. Full-length human HCS was PCR-amplified
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using HCS-pET41a as a template [2], AccuPrime™ Pfx DNA polymerase SuperMix
(Invitrogen, Carlsbad, CA) and the following primers: 5′-
GTTCGAATTCATGGAAGATAGACTCCACATGG-3′ (forward, EcoRI site underlined)
and 5′-GTTTCTCGAGCCGCCGTTTGGGGAGGATGAGG-3′ (reverse, XhoI site
underlined). Following amplification, HCS and pIND (V5) EcoDam vector were digested
with EcoRI and XhoI (Fermentas, Glen Burnie, MD), ligated using Fast-Link™ DNA
Ligation Kit (Epicenter Biotechnologies, Madison, WI), and transformed into MAX
Efficiency® DH5α™ Competent Cells (Invitrogen). The HCS-Dam fusion plasmid was
sequenced (Eurofin MWG Operon, Huntsville, AL) to confirm its identity and was denoted
“HCS-Dam.” Two control plasmids were used in HCS mapping studies. (i) Plasmid pIND
V5 EcoDam [11], codes for Dam only and was used to identify artifactual binding of Dam to
chromatin that was not mediated by HCS. (ii) Plasmid “HCS” codes for full-length human
HCS and was used to identify artifactual adenine methylation in the absence of Dam.
Plasmid HCS was generated as described above for HCS-Dam, but the following reverse
primer was substituted for the original reverse primer:
5′GTTTTCTAGATTACCGCCGTTTGGGGAGGATGAGG-3′ (reverse; XbaI site
underlined). The stop codon in this reverse primer terminates translation after the HCS open
reading frame.
2.2 Cell culture
MCF-7 and MCF-10A cells (ATCC, Manassas, VA) were used for all studies. MCF-7 cells
were cultured in DMEM/F12 media (ATCC) with the following supplements (v/v): 1% L-
glutamine (Invitrogen), 10% fetal bovine serum (Invitrogen), 1% antibiotic/antimycotic
(Invitrogen), 1% nonessential amino acids (Invitrogen), and 0.06% bovine insulin (Sigma-
Aldrich, St. Louis, MO). MCF-10A cells were cultured in mammary epithelial growth media
(MEGM) + bullet kit (Lonza, Basel, Switzerland), 1% (v/v) fetal bovine serum, and 0.05%
(v/v) cholera toxin (Sigma-Aldrich).
2.3 Transfection of cells with HCS-Dam and control plasmids
For transfection with HCS-Dam, EcoDam and HCS plasmids, 3.5 × 106 cells were seeded in
T-75 flasks and allowed to adhere for 18 h, after which time cells were transfected with one
of the three plasmids as follows. DNA was complexed with Lipofectamine (LF) 2000
(Invitrogen) or FugeneHD (Roche, Madison, WI) in serum-free opti-MEM media
(Invitrogen). For MCF-7 cells, 6.75 μg of each plasmid was complexed with 10.2 μl of LF
2000 in a 1:1.5 DNA to lipid ratio (μg of DNA to μl of LF2000). These complexes were
allowed to incubate for 20 min and were then added to each designated flask. For MCF-10A
cells, 8.25 μg of each plasmid was complexed with 20.625 μl of FugeneHD in a 1:2.5 DNA
to Fugene ratio (μg of DNA to μl of FugeneHD). These complexes were incubated for 15
min and were then delivered to each designated flask. Forty-eight hours after transfection,
cells were collected and lysed using protocols specific for isolation of RNA or genomic
DNA.
2.4 Quantitative Real-time PCR (qRT-PCR)
Total RNA was collected using the RNeasy mini kit (Qiagen, Valencia, CA) and reverse
transcribed using the ImProm-II Reverse Transcription System (Promega, Madison, WI).
The cDNA was used to confirm successful transfection of cells with plasmids HCS-Dam,
EcoDam, and HCS, using the following primers and SYBR green (Qiagen) in qRT-PCR
expression analysis: (i) HCS-Dam = 5′-GCAACTCCTTCGACATGCTGAGAAA-3′
(forward, positioned in HCS region) and 5′-TCTTCATGCCGGTACGCGTAGAAT-3′
(reverse, positioned in Dam region); (ii) Dam = 5′-
TCTGGTTGAGCGCCATATTCCAGT-3′ (forward) and 5′-
TGTACAAAGCCAGCAGTTCGTCCA-3′ (reverse); and (iii) HCS = 5′-
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ATGGAAGATAGACTCCACAT-3′ (forward) and 5′-
TGAGACCTGATCCTTAACTTCC-3′ (reverse). Glyceraldehyde 3-phosphate
dehydrogenase was used as the reference gene for qRT-PCR normalization, using primers
5′-TCCACTGGCGTCTTCACC-3′ (forward) and 5′-GGCAGAGATGATGACCCTTT-3′
(reverse) [6]. The cycle threshold values were used to calculate amplicon abundance [26].
2.5 Mapping HCS-binding sites of adenine-methylated sequences
Genomic DNA was purified by using the DNeasy mini kit (Qiagen) 48 h post transfection.
DNA was digested with DpnI (Fermentas) and purified using a PCR purification kit
(Qiagen). The digested DNA was ligated into the pBlueScript II sk(+) vector after vector
linearization with BamHI (Fermentas); the Fast-Link™ DNA Ligation Kit was used for
ligation. Note that digestion with DpnI and BamHI produces compatible overlaps. The
ligation mixture was transformed into MAX Efficiency® DH5α™ Competent Cells and the
cells were plated on LB-ampicillin plates. White colonies were randomly selected for
sequencing by using the T7 promoter primer (Eurofins MWG Operon, Huntsville, AL).
HCS-binding loci were identified by matching sequences against human genome using
NCBI’s BLAST tool, and were defined as sequences within the genes and sequences up to
100,000 basepairs upstream or downstream of the genes.
2.6 Statistics
The GraphPad Prism 5.0 program (La Jolla, CA) was used to plot qRT-PCR graphs. Data
are presented as the mean ± SEM. Multiple comparisons were evaluated by one-way
ANOVA, followed by post hoc Tukey test. Values were considered statistically significant,
if P < 0.05.
3. Results and Discussion
3.1 Plasmid expression
Transfection of mammary cells with plasmids Dam-HCS, EcoDam, or HCS produced the
expected expression patterns compared with non-transfected control cells. When cDNA was
analyzed using PCR primers for HCS, the transcript abundance was 170-fold and 62-fold
greater in MCF-7 cells transfected with HCS and HCS-Dam, respectively, than in non-
transfected control cells (Fig. 1A); the abundance of HCS transcript was not altered by
transfection with EcoDam (negative control) as it did not contain HCS. When cDNA was
analyzed using PCR primers for the HCS-Dam fusion protein, the transcript abundance was
2000-fold greater in MCF-7 cells transfected with HCS-Dam than in non-transfected control
cells (Fig. 1B); the abundance of HCS-Dam fusion transcript was not altered by transfection
with EcoDam and HCS (negative controls) as these controls lacked HCS-Dam fusion. When
cDNA was analyzed using PCR primers for Dam, the transcript abundance was 660-fold and
800-fold greater in MCF-7 cells transfected with EcoDam and HCS-Dam, respectively, than
in non-transfected control cells (Fig. 1C); the abundance of Dam transcript was not altered
by transfection with HCS (negative control) as it did not contain Dam. Results were similar
in MCF-10A cells (Fig. 2).
3.2 HCS-docking sites
Following the validation of expression of fusion and control plasmids, these plasmids were
expressed in MCF-7 and MCF-10A cell lines, genomic sequences methylated by Dam were
cloned into the pBlueScript II sk(+) cloning vector, and then positive clones were obtained
and sequenced. When five clones from HCS-Dam positive MCF-7 cells were annotated by
NCBI’s basic local alignment search tool (BLAST), eight unique HCS-binding sequences,
within specific genes, were detected (Table 1). Each clone returned more than one sequence,
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because of the complimentary ends created during digestion with DpnI and the random
ligation of these fragments during ligation and cloning. Transfection with plasmid HCS
(negative control) did not produce any clones in MCF-7 cells. We conclude that HCS greatly
enhances the binding of Dam at distinct genomic loci. Results in MCF-10A cells were
similar to those in MCF-7, including five clones identified from HCS-Dam positive
MCF-10A cells that contained eight unique sequences when annoted by BLAST, (Table 2).
Within these data, some important observations were noted. First, when MCF-10A cells
were transfected with plasmid HCS, one clone with one single sequence was identified
compared with the seven clones in cells transfected with HCS-Dam, indicating that the false
positive rate due to these artifacts might be up to 14% in Dam-based assays. Also, for the
MCF-10A cell line, a locus within X-linked neuroligin4 gene was disregarded as a potential
HCS docking site, as it appeared due to artifactual methylation by pIND (V5) EcoDam
control. No such artifactual methylation by Dam was observed for MCF-7 cells. Finally,
three HCS-docking sites were found to be common between MCF-7 and MCF-10A cells,
indicating a 26% overlap in the HCS binding regions identified in the two epithelial cell
lines, increasing confidence that the results produced by HCS-Dam technology are real.
Note that clones were selected randomly in this proof-of-concept study and, therefore, one
must not expect a 100% overlap in clones. Comprehensive maps can only be generated by
using microarray-based technologies or high-throughput sequencing and may show an
expected overlap of 100% between the identified genes, as both cell lines used in this study
are of epithelial origin or alternatively could allow for determination of non-overlapping loci
specific for either cell type. Also note that the following gene sets share a common HCS-
docking locus: CRH and RRS1 (Tables 1 and 2), cadherin 8 and cadherin 11 (Table 1) and,
SRY-box4 and prolactin (Table 2).
This study proves feasibility of the DamID technology to identify, for the first time,
potential HCS binding sites in human mammary epithelial cell lines. DamID technology
eliminates the need for large cell numbers and antibodies and thus represents a viable
alternative method to the chromatin immunoprecipitation (ChIP) assay, a frequently used
tool to investigate DNA-chromatin interactions. With the establishment of the ability of
DamID technology to identify chromatin protein binding sites, the future goal of this project
is to use the technology along with cDNA microarray sequencing to monitor chromatin
proteins in small cell samples, such as oocytes. While the combination of techniques
employed in this study only provided a snapshot of events occurring at the genomic level, it
proves the DamID technology’s utility and when combined with cDNA microarray
sequencing, has the potential for full genome analysis.
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Figure 1.
Transcript abundance in MCF-7 cells transfected with plasmids HCS-Dam, EcoDam and
HCS. Transcripts were quantified by qRT-PCR using gene-specific primers for HCS (A),
HCS-Dam fusion (B), and EcoDam (C). Each bar represents the mean ± SEM, n =
3. a,b,cBars with different letters indicate significant differences (P < 0.05) between
treatments.
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Figure 2.
Transcript abundance in MCF-10A cells transfected with plasmids HCS-Dam, EcoDam and
HCS. Transcripts were quantified by qRT-PCR using gene-specific primers for HCS (A),
HCS-Dam fusion (B), and EcoDam (C). Each bar represents the mean ± SEM, n =
3. a,b,cBars with different letters indicate significant differences (P < 0.05) between
treatments.
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Table 1
Genomic HCS binding sites in MCF-7 cells.
MCF-7 HCS-Binding Loci Genes Chromosome GenBank Acession Number
5′- CCACAGAATCAGGGGATAACGCAGGAAAGAACAT- 3′ Inositol
polyphosphate-5-
phosphatase A
10 NM_0055
39.3
5′- CAGGAAAGAACATGTGAGCAAAAG- 3′ Corticotropin
releasing
hormone
precursor (CRH),
And Homolog of
yeast ribosome
biogenesis
regulatory
protein (RRS1)
8 NM_0007
56.2
NM_0151
69.3
5′- ATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTA- 3′ Cadherin 8 and,
Cadherin 11
Type2
preproproteins
16 NM_0017
96.2
NM_0017
97.2
5′- ACCATGCTCTTTCCCCCTTGCAACCTCACTCATTCTCTCTCCTA TTC-3′ Schwannomin
interacting
protein 1
(SCHIP1)
3 NM_0145
75.2
5′- GGTTTTTATCTTTGCAAGCAGCAGAT-3′ Neuron
navigator 3
(NAV3)
12 NM_0149
03.4
5′ ATTCCACACAACATACGAGC-3′ Leptin precursor 7 NM_0002
30.2
5′- AAAGGGATTTTGGGGCATGAGATCATC- 3′ Apoptosis
inhibitor 5
isoform b
11 NM_0065
95.3
5′- AAAGGGATTTTGGGGCATGAGATCATC- 3′ Netrin-G1 ligand 11 NM_0209
29.1
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Table 2
Genomic HCS binding sites in MCF-10A cells.
MCF-10A HCS-Binding Loci Genes Chromosome GenBank Acession Number
5′- CCACAGAATCAGGGGATAACGCAGGAAAGAACAT- 3′ Inositol
polyphosphate-5-
phosphatase A
10 NM_0055
39.3
5′- TCGCCCTATAGTGAGTCGTAT-3′ Homo sapiens myosin,
heavy chain9, non-
muscle (MYH9)
22 NM_0024
73.4
5′- CAGGAAAGAACATGTGAGCAA AAG- 3′ Corticotropin releasing
hormone precursor
(CRH), and Homolog of
yeast ribosome
biogenesis regulatory
protein (RRS1)
8 NM_0007
56.2
NM_0151
69.3
5′- TGAGCTAACTCACATTAATTGCGTTG- 3′ SRY (sex determining
region Y)-box 4, and
Prolactin
6 NM_0031
07.2
NM_0011
63558.1
5′- CCTGTTTTGCAGGGTGCTTT- 3′ Purinergic receptor
P2X5 isoform A and B
17 NM_0025
61.2
5′- GAGCTCCAGCTTTTTTTCTCTTTAG- 3′ Tetratricopeptide repeat
domain 7B
14 XM_5101
18.2
5′- CCTGGGGTGCCTAATGAGTG-3′ CUB and Sushi multiple
domains 1
8 Q96PZ7-1
5′- ATTCCACACAACATACGAGC-3′ Leptin precursor 7 NM_0002
30.2
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